Common cardiovascular drugs and Paxlovid can cause drug-drug interactions: review People who are taking common cardiovascular drugs and given Paxlovid (nirmatrelvir/ritonavir) are at risk of drug-drug interactions, according to a review in the Journal of the American College of Cardiology. Health Canada approves two therapies for COVID-19 treatmentSingle-dose Evusheld is now indicated for treating mild/moderate COVID-19 and Actemra IV is now approved for treating COVID-19 in hospitalized adults. Get your flu shot AND your COVID-19 booster Here's what family doctor Dr. Sohail Gandhi is telling his patients right now. CMAJ report calls for substantial healthcare restructuring to tackle long-COVID burden So much of long COVID continues to confound clinicians. Can mouthwash help in the battle against SARS-CoV-2? Study adds to evidence that antiseptic mouthwash can inhibit the virus. Ontario weighs declaring monkeypox outbreak over, Moore says There haven't been any significant increases in the past few weeks: Ontario's Chief Medical Officer of Health Emerging Omicron subvariants have potential to lead to a spike in COVID-19 cases Reduced or abandoned public health measures speculated to be enhancing the ability of Omicron to develop more immune-evading subvariants. Sponsored From Policy To Practice: How Physicians Can Bring the Latest Covid Vaccine Recommendations to their Patients Young children facing greater risk of catching the flu this season, experts warn Low circulation of the flu over the past two years is a factor, say experts who also fear fewer pandemic measures and reduced vaccinations will increase risks. Tailor antimicrobials to patients’ clinical presentation and risk factors in cases of sepsis Article from Canadian Society of Hospital Pharmacists highlights sepsis guideline updates that impact pharmacists. First Previous 30 31 32 33 34 Next Last
